Difference between revisions of "QIBA Overview"
Jump to navigation
Jump to search
| (13 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
| − | QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry . This involves: | + | QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry . |
| + | |||
| + | This involves: | ||
:* collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time. | :* collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time. | ||
| Line 13: | Line 15: | ||
==See Also== | ==See Also== | ||
| − | *[ | + | *[https://tinyurl.com/QIBA-Overview QIBA Overview Fact Sheet] |
*[http://www.rsna.org/qiba RSNA QIBA page] | *[http://www.rsna.org/qiba RSNA QIBA page] | ||
**[[Media:QIBA task force report 11-3-11.pdf|QIBA Task Force Report]] ''August 2011'' | **[[Media:QIBA task force report 11-3-11.pdf|QIBA Task Force Report]] ''August 2011'' | ||
| Line 24: | Line 26: | ||
:* QIBA Japan | :* QIBA Japan | ||
:*[[Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)]] | :*[[Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)]] | ||
| + | |||
| + | TODO - add link to Collaborations, and highlight contact people (and get them to link to QIBA) | ||
| + | TODO - turn See also into more of a menu showing what you get at each link | ||
| + | TODO - try and pull in the org chart - high density information, good impact on viewer | ||
Latest revision as of 04:26, 19 November 2019
QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry .
This involves:
- collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time.
- accelerating the development and adoption of hardware and software standards needed to achieve accurate and reproducible quantitative results from imaging methods.
QIBA develops Profile specifications and coordinates the necessary research and qualification groundwork.
For more detail, refer to the Education page.
See Also
Related Activities
- UPICT
- Quantitative Imaging Data Warehouse (QIDW) - manages many of the datasets used in developing and testing QIBA Profiles
- EIBALL
- QIBA Japan
- Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)
TODO - add link to Collaborations, and highlight contact people (and get them to link to QIBA) TODO - turn See also into more of a menu showing what you get at each link TODO - try and pull in the org chart - high density information, good impact on viewer